Navigation Links
NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
Date:2/8/2010

ROCKVILLE, Md., Feb. 8 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) announced today new data from a clinical study that began in May of 2009 among healthy adults 18 to 49 years of age with Novavax's trivalent seasonal influenza Virus-like Particle (VLP) vaccine. The vaccine matched the influenza strains recommended for the 2008-2009 influenza season including H1N1 A/Brisbane/59/2007, H3N2 A/Brisbane/10/2007, and B/Florida/04/2006 strains. The study enrolled 241 subjects, including 221 who were randomized to receive either VLP vaccine at 15 mcg or 60 mcg doses or a placebo and 20 subjects who received a licensed inactivated influenza vaccine (TIV).  

Novavax reported safety and hemagglutination inhibition (HAI) antibody titers from this study in a poster presentation at the 47th Annual Meeting of the Infectious Diseases Society of America (IDSA).  In addition to the HAI titers, functional antibody against the Neuraminidase enzyme was measured in the sera of immunized subjects using a neuraminidase inhibition assay (NAI) developed by Novavax scientists.  Inhibition of neuraminidase activity may be important in reducing the spread of influenza virus down the respiratory tract and severe influenza disease.  Since neuraminidase mutates less rapidly than hemagglutinin(HA), the antibody against neuraminidase may be more effective in protecting against drifted seasonal strains or new, emerging strains of influenza virus.  

In continued evaluation of the May 2009 clinical study, Novavax tested volunteers for NAI against H3N2/Brisbane and B/

SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
2. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
3. NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico
4. Novavax to Present at 8th Annual BIO Investor Forum 2009
5. Novavax Launches Pivotal Clinical Study of Novel 2009 H1N1 VLP Flu Vaccine in Mexico
6. NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone
7. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
8. Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate
9. Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference
10. Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate
11. Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... March 27, 2015  The quality function within the ... products meet quality standards at every stage of the ... quality leaders also have the challenge of balancing quality ... Those who don,t effectively balance these priorities risk funding ... marketplace failure and regulatory scrutiny. For the ...
(Date:3/27/2015)... NEW YORK , March 27, 2015 ... of Ohr Pharmaceutical, Inc. (NASDAQ: OHRP ) concerning ... certain statements issued by the Company in connection with ... information, GO TO: http://zlk.9nl.com/ohr-pharmaceutical-ohrp or contact ... jlevi@zlk.com or by telephone at (212) 363-7500, ...
(Date:3/27/2015)... - Medicure Inc. (the "Company") (TSXV:MPH, OTCQB:MCUJF) announces today ... of an aggregate of 236,070 options to certain directors, ... Company pursuant to the Company,s Stock Option Plan. Of ... tenth anniversary of the date of grant, 5,000 are ... date of grant and 50,000 are set to expire ...
Breaking Medicine Technology:New Medical Device Quality Study Finds Regulatory Environment is Boosting Quality Spending, Especially for Large Companies 2
... March 17 Kendle (Nasdaq: KNDL ), a leading, ... , Vice President, Asia/Pacific will address the World Pharma ... at the Raffles City Convention Centre in Singapore . Dr. ... scheduled for March 18 at 2 p.m. ...
... announced that it has received approval from the U.S. Food & Drug Administration to market Alprazolam orally disintegrating tablets. Distribution of the product will commence immediately.   , ... , ... ... ...
Cached Medicine Technology:Kendle Executive to Share Insights at World Pharma Trials Asia 2010 2Kendle Executive to Share Insights at World Pharma Trials Asia 2010 3Actavis Receives Approval of Alprazolam ODT in the U.S. 2Actavis Receives Approval of Alprazolam ODT in the U.S. 3
(Date:3/28/2015)... "Necrorun" was featured on NewsWatch as part ... the latest and coolest applications on the market for ... NewsWatch and technology expert, conducted the app review and ... runner game with knights, nature, and peasants. , ... according to Eurogamer. The popularity of these games grew ...
(Date:3/28/2015)... The California-based leading wig brand UniWigs ... shopping on UniWigs during the Easter Holidays from today ... promotion on April Fools’ Day. , As the winter ... the corner. Easter Festival, with religious origins to countries ... holiday after Christmas. The best wig provider, UniWigs, would ...
(Date:3/28/2015)... Centurion Service Group will be hosting a live on-site and ... Las Vegas warehouse, located at 4606 Andrews St. Suite 3, ... equipment from hospitals and surgery centers from around the United ... Buyers will find items of all types including anesthesia, endoscopy, ... Erik Tivin, CEO of Centurion. , Among the sale’s ...
(Date:3/28/2015)... Vegas, NV (PRWEB) March 28, 2015 ... may not be necessary, according to research presented today ... AOSSM ) Specialty Day. , “Our study compared results ... 25 who underwent an additional glenohumeral joint capsule release ... commented George Murrell MD, PhD, lead author from St. ...
(Date:3/28/2015)... 28, 2015 Lately the student-athlete ... recent changes and proposals around the NCAA. In a ... former collegiate student-athletes across a spectrum of universities and ... common challenges. The special panel consists of athletes who ... ranging from football, track and field, baseball, and volleyball. ...
Breaking Medicine News(10 mins):Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:UniWigs Is Sending Out Mysterious Gifts During the Easter Holidays 2Health News:Medical Equipment Auction to Take Place in North Las Vegas 2Health News:No Need to Delay Rotator Cuff Surgery, Study Shows 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 2Health News:SCI TV Panel of Former College Athletes Discusses Student Athlete Experience 3
... Control and Prevention (China CDC) and Fred Hutchinson Cancer ... a collaboration agreement. It marks the first such agreement ... center. The agreement a memorandum of understanding ... that support and contribute to the prevention, early detection, ...
... Reporter , THURSDAY, Oct. 28 (HealthDay News) -- A new ... appears to be more accurate than current noninvasive tests such ... The search for a highly accurate, noninvasive alternative to invasive ... of colon cancer research. In a preliminary trial, the ...
... , THURSDAY, Oct. 28 (HealthDay News) -- The H1N1 flu ... of children with a serious bacterial infection called empyema, a ... tissues surrounding the lungs, frequently requires a chest tube or ... often occurs as a complication of pneumonia. Researchers studied ...
... , THURSDAY, Oct. 28 (HealthDay News) Early humans ... years ago in Africa, more than 50,000 years earlier than ... evidence that modern behavior developed over time during the Middle ... to Europe, as some scientists have thought. Researchers from ...
... nervous system turn Neuroimmunology into one of the most ... 30th takes place in Sitges (Barcelona, Spain) the X ... Neuroimmunology. This event highlights the advances that have been ... also highlights the long road ahead. New biomarkers, potential ...
... reassigned to different prescription drug plans because Part D ... than the actual costs incurred, according to a study ... report describes how a system designed to encourage competition ... has led companies to raise their premiums in an ...
Cached Medicine News:Health News:Hutchinson Center and China CDC sign agreement for research and training collaboration 2Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 2Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 3Health News:Noninvasive Test for Colon Cancer Shows Promise in Early Trial 4Health News:H1N1 Flu Linked to Surge in Pneumonia Complication 2Health News:Early Humans More Advanced Than Thought 2Health News:Multiple sclerosis will become a controlled disease like AIDS 2Health News:Study identifies flaws in Medicare prescription drug program 2
Lorgnette pinhole occluder...
9 inch double ended with one end black and the other end with 49 holes...
6 inch hand held occlcuder with 49 holes...
Double Ended Occluders...
Medicine Products: